Showing results (1631-1640 of 1,753) with videos related to
Sort By:
Pageof 176
Psychological Medicine|December 7, 2016
Patterns and correlates of major depression in Chinese adults: a cross-sectional study of 0.5 million men and womenY Chen, D Bennett, R Clarke, et al.Neurology|September 1, 1996
A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's diseaseL J Thal, A Carta, W R Clarke, et al.The EMBO Journal|May 24, 2008
The Moraxella adhesin UspA1 binds to its human CEACAM1 receptor by a deformable trimeric coiled-coilRebecca Conners, Darryl J Hill, Elena Borodina, et al.The Journal of Biological Chemistry|March 30, 2001
Inhibition of the G2 DNA damage checkpoint and of protein kinases Chk1 and Chk2 by the marine sponge alkaloid debromohymenialdisineD Curman, B Cinel, D E Williams, et al.Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
The impact of COVID-19 on African American communities in the United StatesE Cyrus, R Clarke, D Hadley, et al.Proceedings of the National Academy of Sciences of the United States of America|September 30, 2010
Pharmacological chaperone for the structured domain of human prion proteinAndrew J Nicoll, Clare R Trevitt, M Howard Tattum, et al.Journal of Medicinal Chemistry|March 6, 2014
Targeting Staphylococcus aureus quorum sensing with nonpeptidic small molecule inhibitorsEwan J Murray, Rebecca C Crowley, Alex Truman, et al.Brain, Behavior, and Immunity|April 17, 2017
Chronic sleep restriction promotes brain inflammation and synapse loss, and potentiates memory impairment induced by amyloid-β oligomers in miceGrasielle C Kincheski, Isabela S Valentim, Julia R Clarke, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 18, 2013
Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfaRaphael Schiffmann, Markus Ries, Derek Blankenship, et al.Neurology|January 13, 2012
Cerebral hemodynamics and cognitive impairment: baseline data from the RECON trialR S Marshall, J R Festa, Y K Cheung, et al.Pageof 176